GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Q-linea AB (OSTO:QLINEA) » Definitions » Additional Paid-In Capital

Q-linea AB (OSTO:QLINEA) Additional Paid-In Capital : kr1,483.36 Mil(As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Q-linea AB Additional Paid-In Capital?


Q-linea AB's quarterly additional paid-in capital increased from Jun. 2023 (kr1,234.97 Mil) to Sep. 2023 (kr1,483.36 Mil) but then stayed the same from Sep. 2023 (kr1,483.36 Mil) to Dec. 2023 (kr1,483.36 Mil).

Q-linea AB's annual additional paid-in capital stayed the same from Dec. 2021 (kr1,234.97 Mil) to Dec. 2022 (kr1,234.97 Mil) but then increased from Dec. 2022 (kr1,234.97 Mil) to Dec. 2023 (kr1,483.36 Mil).

Q-linea AB Additional Paid-In Capital Historical Data

The historical data trend for Q-linea AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q-linea AB Additional Paid-In Capital Chart

Q-linea AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only 697.06 951.02 1,234.97 1,234.97 1,483.36

Q-linea AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,234.97 1,234.97 1,234.97 1,483.36 1,483.36

Q-linea AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Q-linea AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Q-linea AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Q-linea AB (OSTO:QLINEA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Q-linea AB (OSTO:QLINEA) » Definitions » Additional Paid-In Capital
Comparable Companies
XSAT:BPCINS OSTO:ORTI A OSTO:IZAFE B NGM:PRLD XSAT:BIBB XSAT:MEDIMI OSTO:BIOS XSAT:ODIN XSAT:AUDNTS OSTO:S2M ISRG XPAR:EL BDX XSWX:ALC TSE:7741 WST OCSE:COLO B RMD TSE:4543 XSWX:STMN
Traded in Other Exchanges
3F8:Germany
Address
Dag Hammarskjolds vag 52 A, Uppsala, SWE, SE-752 37
Website
https://www.qlinea.com
Q-linea AB is a company that develops solutions for improved infectious disease diagnostics. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.

Q-linea AB (OSTO:QLINEA) Headlines

No Headlines